Corrections: March 1, 2021
Feb. 28, 2021
OPINION
An Op-Ed essay on Tuesday about medical care during the pandemic misidentified the source of a statistic about missed preventive screenings. It is the Prevent Cancer Foundation, not The Journal of the National Medical Association.
Errors are corrected during the press run whenever possible, so some errors noted here may not have appeared in all editions.
To contact the newsroom regarding correction requests, complaints or other comments about our coverage, please email
Anthony Henry and Willie Underwood III have a lot in common.
Both are Black men whose gene pool originated in West Africa, suggesting higher risks for aggressive prostate cancer. Both of their fathers were diagnosed with prostate cancer. Henry s father was diagnosed at age 64 and died at 68 from prostate cancer, and Underwood s dad was diagnosed with prostate cancer in his early 70s and is still alive at 81.
Both sons were diagnosed with prostate cancer at a young age: Underwood at 48 and Henry at 54.
Underwood in 2012 was diagnosed with a Gleason 3+4, known today as a favorable intermediate-risk prostate cancer. He qualified in some protocols for active surveillance (AS), monitoring the disease with prostate-specific antigen (PSA) tests, digital rectal exams, biopsies, and multi-parametric magnetic resonance imaging.
E-Mail
In a review of national firearm data spanning more than 20 years, researchers at Oregon Health & Science University have identified alarming trends regarding increasing rates of firearm-related deaths among some of America s youngest residents.
According to lead researcher Archie Bleyer, M.D., the rate of unintentional firearm deaths in children ages 1 - 4 increased exponentially at an average annual percent of 4.9 between 1999 and 2018, with the greatest impact among non-Hispanic Black and White children. This rate is more than eight times higher than any other highly developed country worldwide. What is perhaps most distressing about these findings, is that nearly 90% of these instances took place in or near the victims home, and 100% of the events were preventable, says Bleyer, a clinical research professor in the Department of Radiation Medicine, OHSU Knight Cancer Institute, OHSU School of Medicine.
PBS Airdate: February 6, 2007
NARRATOR: 1939: A chemist at a midwestern paint company makes a startling discovery, one that could improve the health of millions of people. The company wants him to stick to making paint, but this man has always gone his own way. He was the grandson of Alabama slaves, yet he went on to become one of America s great scientists.
HELEN PRINTY (Julian Laboratories Chemist) : He had to fight to overcome the odds of being a black man in America.
JOHN KENLY SMITH (Historian) : The chemical world was a club, and outsiders were not really all that welcome.
PETER WALTON (Julian Laboratories Employee) : We lived, for the most part, in a highly stressed, very competitive environment.
Amgen and Novartis
It took meeting a college classmate who had been diagnosed with migraine for Karamo Brown, a cast member of the Netflix show
Queer Eye, to realize there was a name and diagnosis for the debilitating headaches he’d been experiencing since he was a teenager. It clicked for me, says Brown, now 40. “I was like, ‘Oh, you can actually go to the doctor for this, you can talk to somebody? Oh, my gosh!’ And also, ‘I’m not alone with this feeling? You’re feeling exactly what I’m feeling?’” he recalls.
Unfortunately, Brown’s experience is not unusual. The majority of people with migraine never seek medical care for their pain, and more than half of people with migraine are never diagnosed, according to the Migraine Research Foundation.